Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in active rheumatoid arthritis refractory to biologic disease-modifying antirheumatic drugs
Young Ho Lee, Gwan Gyu Song
Topics & Concepts
TofacitinibMedicineRheumatoid arthritisPlaceboAdverse effectInternal medicinePharmacologyAlternative medicinePathologyRheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and TreatmentsAutoimmune and Inflammatory Disorders Research